Evogene Stock

Evogene Revenue 2024

Evogene Revenue

15.4 M USD

Ticker

EVGN

ISIN

IL0011050551

WKN

A0Q7UP

In 2024, Evogene's sales reached 15.4 M USD, a 173.12% difference from the 5.64 M USD sales recorded in the previous year.

The Evogene Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e40.57-5,92
2025e20.5-11,71
2024e15.4-15,59
20235.64-42,57
20221.68-282,74
20210.93-596,77
20201.0445,19
20190.7556,00
20181.75-54,29
20173.38-32,54
20166.54-18,65
201511.1312,31
201414.5126,67
201317.5840,73
201217.0744,05
201114.941,21
201012.5653,74
20099.9950,35
20083.6458,79
20070.2580,00

Evogene Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Evogene, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Evogene from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Evogene’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Evogene. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Evogene’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Evogene’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Evogene’s growth potential.

Evogene Revenue, EBIT and net profit per share

DateEvogene RevenueEvogene EBITEvogene Net Income
2026e40.57 M undefined-13.89 M undefined-9.7 M undefined
2025e20.5 M undefined-21.86 M undefined-17.86 M undefined
2024e15.4 M undefined-20.64 M undefined-18.81 M undefined
20235.64 M undefined-26.52 M undefined-23.88 M undefined
20221.68 M undefined-30.32 M undefined-26.64 M undefined
2021930,000 undefined-30.86 M undefined-27.79 M undefined
20201.04 M undefined-24.81 M undefined-23.37 M undefined
2019750,000 undefined-21.04 M undefined-18.11 M undefined
20181.75 M undefined-19.92 M undefined-20.76 M undefined
20173.38 M undefined-21.91 M undefined-20.84 M undefined
20166.54 M undefined-21.07 M undefined-19.59 M undefined
201511.13 M undefined-17.86 M undefined-17.21 M undefined
201414.51 M undefined-15.21 M undefined-14.53 M undefined
201317.58 M undefined-8.63 M undefined-8.88 M undefined
201217.07 M undefined-3.16 M undefined-2.52 M undefined
201114.9 M undefined-3.08 M undefined650,000 undefined
201012.56 M undefined-1.98 M undefined-6.97 M undefined
20099.99 M undefined320,000 undefined-3.41 M undefined
20083.64 M undefined-4.41 M undefined-5.11 M undefined
2007250,000 undefined-3.91 M undefined-4.88 M undefined

Evogene stock margins

The Evogene margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Evogene. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Evogene.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Evogene's sales revenue. A higher gross margin percentage indicates that the Evogene retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Evogene's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Evogene's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Evogene's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Evogene. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Evogene's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Evogene Margin History

Evogene Gross marginEvogene Profit marginEvogene EBIT marginEvogene Profit margin
2026e-42.57 %-34.25 %-23.92 %
2025e-42.57 %-106.64 %-87.1 %
2024e-42.57 %-134.01 %-122.13 %
2023-42.57 %-470.28 %-423.39 %
2022-282.74 %-1,804.76 %-1,585.71 %
2021-596.77 %-3,318.28 %-2,988.17 %
202045.19 %-2,385.58 %-2,247.12 %
201956 %-2,805.33 %-2,414.67 %
2018-54.29 %-1,138.29 %-1,186.29 %
2017-32.54 %-648.22 %-616.57 %
2016-18.65 %-322.17 %-299.54 %
201512.31 %-160.47 %-154.63 %
201426.67 %-104.82 %-100.14 %
201340.73 %-49.09 %-50.51 %
201244.05 %-18.51 %-14.76 %
201141.21 %-20.67 %4.36 %
201053.74 %-15.76 %-55.49 %
200950.35 %3.2 %-34.13 %
200858.79 %-121.15 %-140.38 %
200780 %-1,564 %-1,952 %

Evogene Aktienanalyse

What does Evogene do?

Evogene Ltd is an Israeli biotechnology company that focuses on the application of computational biology and genomics to agriculture and biology. The company originated from a spin-off of the Weizmann Institute of Science and was founded in 2002. Today, it is a leading global provider of biotechnology solutions for the agriculture and biotechnology industry. Evogene's business model is based on providing innovative technologies and services for its customers, aiming to improve plant development, particularly in terms of resistance to environmental stress factors and pests. To achieve this, the company utilizes modern biotechnology methods and leverages artificial intelligence. It employs advanced machine learning and large-scale data analysis techniques to gain a better understanding of underlying biological processes. Evogene operates in three core areas: agricultural biotechnology, drug discovery biotechnology, and biomaterials. The company is capable of offering customized biological solutions tailored to the specific needs of its customers. Agricultural biotechnology is one of Evogene's key sectors. It utilizes state-of-the-art technologies and methods to generate plant resistance to pests and environmental factors. With the help of a reliable pipeline of innovative products such as seeds, biostimulants, and fertilizers, Evogene aims to play an important role in food security, environmental sustainability, and resilience to climate change. The company has a strong product pipeline aimed at improving nutrient efficiency of crops while reducing environmental impact from pesticide and fertilizer use. One such product resulting from this pipeline is EvoCanna, which utilizes modern genomics methods to optimize hemp plants in terms of phytocannabinoid biosynthesis. The goal of Evogene's drug discovery biotechnology and biomaterials sector is to develop innovative and effective medicines for diseases such as cancer and obesity. The company utilizes modern machine learning and large-scale data analysis methods to identify the potential of new drug candidates. In the biomaterials sector, Evogene aims to develop innovative technologies and solutions for better and more sustainable use of natural resources. An important application of this concept is biostimulants, which can improve the growth rate, stress tolerance, and yield of crops. Additionally, the company can offer new materials and environmentally friendly solutions in the packaging industry. Overall, Evogene has achieved impressive success in recent years and established itself as a leading biotechnology company. By utilizing cutting-edge technologies, methods, and scientific concepts, particularly artificial intelligence and machine learning, and by operating as a responsible company in the fields of agriculture, biomaterials, and programming, Evogene is able to offer innovative biotechnological solutions. The company is currently well-equipped and has a promising pipeline of groundbreaking innovation projects that embody the desire for a sustainable worldview. Evogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Evogene's Sales Figures

The sales figures of Evogene originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Evogene’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Evogene's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Evogene’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Evogene stock

How much revenue did Evogene generate this year?

Evogene has achieved a revenue of 15.4 M USD this year.

How much was the turnover of the company Evogene compared to the previous year?

The revenue of Evogene has increased by 173.12% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Evogene?

The revenue of Evogene is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Evogene measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Evogene so important for investors?

The revenue of Evogene is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Evogene pay?

Over the past 12 months, Evogene paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evogene is expected to pay a dividend of 0 USD.

What is the dividend yield of Evogene?

The current dividend yield of Evogene is .

When does Evogene pay dividends?

Evogene pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evogene?

Evogene paid dividends every year for the past 0 years.

What is the dividend of Evogene?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evogene located?

Evogene is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evogene kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evogene from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Evogene pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Evogene in the year 2023?

In the year 2023, Evogene distributed 0 USD as dividends.

In which currency does Evogene pay out the dividend?

The dividends of Evogene are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Evogene

Our stock analysis for Evogene Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evogene Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.